Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
VANCOUVER, March 20 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the Credit Suisse Global Leveraged Finance Conference, which is being held March 24-27 in Phoenix, Arizona.
Mr. Thomas Bailey, Angiotech's Chief Financial Officer, is scheduled to present on Wednesday, March 26, beginning at approximately 8:00 am Mountain Time. A question and answer session will immediately follow the presentation. Presentations at this conference will not be webcast. More information is available on the Angiotech website (www.angiotech.com) under the Investors section.
About Angiotech Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), please visit our website at www.angiotech.com. CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com
CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech
2008-03-20 16:12:00 0317613 PRNEWSWIRE
HOME || Press Release Archive || © Leigh Media Corporation || Terms of Use || Privacy Policy || Publish Your Press Release Here |